0001209191-19-033695.txt : 20190531
0001209191-19-033695.hdr.sgml : 20190531
20190531171238
ACCESSION NUMBER: 0001209191-19-033695
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190510
FILED AS OF DATE: 20190531
DATE AS OF CHANGE: 20190531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JACOBS JOEY A
CENTRAL INDEX KEY: 0001243878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 19871376
MAIL ADDRESS:
STREET 1: 830 CRESCENT CENTER DRIVE
STREET 2: SUITE 610
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-10
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001243878
JACOBS JOEY A
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2019-05-10
4
P
0
931
5.92
A
82651
D
Common Stock
2019-05-13
4
P
0
526
5.67
A
83177
D
Common Stock
2019-05-14
4
P
0
66
5.48
A
83243
D
Common Stock
2019-05-15
4
P
0
677
6.00
A
83920
D
Common Stock
2019-05-16
4
P
0
301
5.99
A
84221
D
Common Stock
2019-05-17
4
P
0
794
6.20
A
85015
D
Common Stock
2019-05-20
4
P
0
850
6.89
A
85865
D
Common Stock
2019-05-21
4
P
0
850
6.49
A
86715
D
Common Stock
2019-05-22
4
P
0
850
6.49
A
87565
D
Common Stock
2019-05-23
4
P
0
850
6.44
A
88415
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.
Joey A. Jacobs by /s/ Michael Bonner as attorney-in-fact
2019-05-31